Nov 17, 2022

Researchers, Providers, and Programs Recognized with National Cancer Community (C2) Awards

Huntsman Cancer Institute’s Doug Fair, MD, and Center for HOPE team earned 2022 Cancer Community (C2) awards for their outstanding work and contributions to cancer research and patient care. Former Huntsman Cancer Institute researcher Charles Rogers, PhD, was also honored with an award. Alana Welm, PhD, and Kathi Mooney, PhD, RN were also featured as award finalists.

Nov 14, 2022

Moderate Exercise Helps Colorectal Cancer Patients Live Longer by Reducing Inflammation and Improving Gut Bacteria, including in Patients Who Are Obese

A brisk walk for 20 minutes a day may not sound like much, but it could make a big difference for colorectal cancer patients. Regular physical activity reduces inflammation by improving the gut microbiome of patients, including patients who are obese, scientists at Huntsman Cancer Institute found. They researched the impact of exercise on the gut microbiome, the trillions of bacteria that live in our digestive system. Investigators found moderate exercise improved outcomes in colorectal cancer, the third most common cancer in the United States, excluding skin cancers. Scientists explain why their findings are so significant.

Nov 11, 2022

Huntsman Cancer Institute Designated as First Clinical Research Center of Excellence

Pheochromocytoma or paraganglioma are rare neuroendocrine tumors that can be hereditary and passed down to children. Due to its outstanding work providing high-quality treatment, care, education, and clinical trials to patients, Huntsman Cancer Institute has been designated as the first Clinical and Research Center of Excellence by the Pheo Para Alliance, an organization working to raise awareness.

Nov 09, 2022

New Vice President Named At Huntsman Cancer Foundation

Huntsman Cancer Foundation president and COO, Susan Sheehan, has promoted Loren Savage to vice president for the foundation. Savage began working for the foundation six years ago and has been recognized for his leadership through a succession of promotions. Throughout his tenure, he has contributed to increased donations leading to new facility construction and advancements in cancer research. Savage brings more than 23 years of experience in non-profit work to his new role with the foundation.

Nov 04, 2022

CDC Data Suggests Attitudes Are Shifting about the HPV Vaccine: Utah Vaccine Rates among Teens Increased more than 16%

Many more Utah teens are getting vaccinated for HPV, protecting them against six types of cancer. The state saw a significant increase in HPV vaccinations after a long history of mixed messages and misunderstandings about the vaccine. Huntsman Cancer Institute experts explain what’s working, and one woman tells about her harrowing cancer journey.

Oct 24, 2022

Jason Hunt, MD, Announced as Interim Chair for New Department of Otolaryngology

Jason Hunt, MD, FACS, clinical director of head and neck surgical oncology at Huntsman Cancer Institute, has been named the interim chair of the University of Utah Health Department of Otolaryngology – Head and Neck Surgery.

Oct 11, 2022

Scientists are One Step Closer to Stopping Drug-Resistant Tumors from Growing

Researchers at Huntsman Cancer Institute have solved a long-standing mystery about how a cancer-promoting protein causes drug-resistant tumors to grow. They hope the discovery leads to more effective cancer drugs. Ben Myers, PhD, explains how this new science is closing the gap in understanding brain and skin tumors and how to combat them.

Oct 06, 2022

BRIDGE Study Finds Disparities in Family History Information in the Electronic Health Record

Patients from historically medically underserved groups, including patients of color and those who are Spanish-speaking, have less cancer family history information available to them. In addition, existing health records are less comprehensive, according to a study published October 4 in the Journal of the American Medical Association Network Open.